StratiCELL

Gembloux, Belgium Founded: 2005 • Age: 21 yrs Acquired By Plant Advanced Technologies
Integrated solution provider for in vitro testing of skin care and dermatology products

About StratiCELL

StratiCELL is a Healthcare company based in Gembloux (Belgium) founded in 2005, and was acquired by Plant Advanced Technologies in January 2016. Integrated solution provider for in vitro testing of skin care and dermatology products. The company has 11 employees. StratiCELL offers products and services including Cosmetic Testing, Dermatology Testing, and MicroBIOS Platform. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Analytical Testing.

Company details

StratiCell was founded in 2005 in Gembloux, Belgium, where in vitro testing services for dermatological actives and products are conducted following topical or systemic applications. Testing is performed on monolayer cell cultures, reconstituted human epithelia, and human skin biopsies within the biotechnology sector. The company was acquired in January 2016 by Plant Advanced Technologies for an undisclosed amount.

Key Metrics

Products & Services of StratiCELL

StratiCELL offers a comprehensive portfolio of products and services, including Cosmetic Testing, Dermatology Testing, and MicroBIOS Platform.

Cosmetic Testing
Research Services

In vitro testing for cosmetic claims and ingredient efficacy

Dermatology Testing
Medical Research

Screening for drug effects on skin biology and conditions

MicroBIOS Platform
Biological Screening

Platform for testing impacts on skin microbiome and infections

Funding Insights of StratiCELL

  • Total Rounds 1
  • Last Round Grant β€” $440,382
  • First Round $440,382

    (Oct 2020)

  • Investors Count 1

All 1 funding rounds of StratiCELL with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2020$440,382Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in StratiCELL

StratiCELL has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Plant Advanced Technologies and European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Plant biotechnology is applied to cosmetic and pharmaceutical uses.
2005plantadvanced.comNancy, France
Premium access

Investor details for StratiCELL

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of StratiCELL

3 dated milestones of StratiCELL across 15 years, from founding to its latest funding, stage changes and deals.

  1. Founded StratiCELL is founded.
  2. Exit Acquired by Plant Advanced Technologies.
  3. Funding First funding round of $440K.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about StratiCELL

StratiCELL was founded in 2005 and raised its 1st funding round 15 years after it was founded.

StratiCELL is headquartered in Gembloux, Belgium. It is registered at Gembloux, Namur, Belgium.

StratiCELL has 11 employees.

StratiCell was founded in 2005 in Gembloux, Belgium, where in vitro testing services for dermatological actives and products are conducted following topical or systemic applications. Testing is performed on monolayer cell cultures, reconstituted human epithelia, and human skin biopsies within the biotechnology sector. The company was acquired in January 2016 by Plant Advanced Technologies for an undisclosed amount.

StratiCELL offers Cosmetic Testing, Dermatology Testing, and MicroBIOS Platform.

StratiCELL has 2 investors. Key investors include Plant Advanced Technologies, and European Union.

StratiCELL operates through Straticell.

Yes. StratiCELL was acquired by Plant Advanced Technologies in January 2016.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available